Recruiting

A Study of Mealtime Insulin LY900014 in Participants with Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

I8B-MC-ITSW - ClinicalTrials.gov - NCT04605991

This study is being done to evaluate glycemic control in participants with type 2 diabetes who are taking mealtime insulin LY900014 in combination with long-acting insulin glargine.
How long will I be in the trial?
The study will last about 19 weeks and may include up to 13 visits.
Email
Recruiting

A Study of Mealtime Insulin LY900014 in Participants with Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

I8B-MC-ITSW - ClinicalTrials.gov - NCT04605991

This study is being done to evaluate glycemic control in participants with type 2 diabetes who are taking mealtime insulin LY900014 in combination with long-acting insulin glargine.
How long will I be in the trial?
The study will last about 19 weeks and may include up to 13 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have a diagnosis of type 2 diabetes for at least 1 year

Participants must have already been treated with long-acting and mealtime insulins required for study participation

Participants blood glucose levels must be within allowed limits for study participation

Participants must NOT

Participants must not have had emergency treatment for very low blood glucose or very high blood glucose within the past 6 months

Participants must not be taking certain diabetes medications that are not allowed for study participation

Participants must not have major problems with their heart, kidney, liver, or have a blood disorder

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY900014

Could I receive a Placebo?

no

Enrollment Goal

167

Trial Dates

November 2020 - September 2021

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have a diagnosis of type 2 diabetes for at least 1 year

Participants must have already been treated with long-acting and mealtime insulins required for study participation

Participants blood glucose levels must be within allowed limits for study participation

Participants must NOT

Participants must not have had emergency treatment for very low blood glucose or very high blood glucose within the past 6 months

Participants must not be taking certain diabetes medications that are not allowed for study participation

Participants must not have major problems with their heart, kidney, liver, or have a blood disorder

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY900014

Could I receive a Placebo?

no

Enrollment Goal

167

Trial Dates

November 2020 - September 2021

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Adult Type 2 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?